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Abstract. Type XI collagen is a structural component 
of the cartilage extracellular matrix and plays an impor- 
tant role in skeletal morphogenesis. As a step toward 
defining the molecular mechanisms responsible for the 
regulation of type XI collagen expression, we charac- 
terized the promoter region of the mouse a2(XI) col- 
lagen gene (Collla2). We also generated transgenic 
mice harboring various fragments of the promoter and 
the first intron of Collla2 linked to the Escherichia coli 
13-galactosidase gene to identify the c/s-acting elements 
responsible for tissue- and site-specific expression dur- 
ing development. Cloning and sequence analysis of the 
5' flanking region of Collla2 showed that the putative 
3' end of the retinoid X receptor 13 gene was located 
742 bp upstream of the Collla2 start site. This sug- 
gested that the promoter region of Collla2 was local- 
ized within this 742-bp sequence, which contained mul- 
tiple consensus regulatory elements. Examination of 
the transgenic mice revealed that the longest DNA con- 
struct (containing the entire promoter and first intron 
sequences) directed lacZ expression in the notochord 
as well as in the primordial cartilage throughout the 
body, with the pattern of expression mimicking that of 
endogenous Collla2 transcripts. On the other hand, 
deletion of the upstream ~290 bp resulted in the elimi- 
nation of lacZ expression in the primordial cartilage of 
the carpals, tarsals, and vertebral bodies, whereas lacZ 
expression in the notochord and in the other primordial 
cartilage elsewhere was not affected. Deletion of the 
first intron sequence also resulted in the loss of lacZ ex- 
pression in the primordial cartilage of the carpals, tar- 
sals, and vertebral bodies, as well as in the notochord. 
These results demonstrate that the upstream 742-bp 
and first intron segments of the mouse Collla2 gene 
contain the necessary information to confer high level 
tissue-specific expression in mouse embryos. In addi- 
tion, our observations suggest the presence of site-spe- 
cific cis-acting elements that control Colllla2 gene ex- 
pression in different cartilaginous components of the 
skeleton. 
T  H~  collagen  superfamily consists  of  various  col- 
lagens, which play an important role as structural 
components in the connective tissue. Among them, 
types II, IX, and XI collagens are predominantly found in 
hyaline cartilage,  where they form heterotypic fibrils that 
confer tensile strength and provide a scaffolding for matrix 
proteoglycans (Kielty et al., 1993). The type XI collagen 
molecule is thought to coassemble  with type II collagen 
molecules to form fibrils, whereas type IX collagen is asso- 
ciated with the surface of the fibrils (Mendler et al., 1989; 
Vaughan et al.,  1988). The type XI collagen  molecule is 
composed of three distinct subunits: al(XI), c~2(XI), and 
c~3(XI) (Morris and B~ichinger, 1987). The c~3(XI) chain is 
believed to be a posttranslational variation product of the 
cd(II) collagen  gene  (Furuto and Miller,  1983), whereas 
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the cO(XI) and a2(XI) chains are distinct  gene products 
(Bernard et al., 1988; Kimura et al., 1989). 
The function of type X! collagen is still obscure.  How- 
ever, emerging evidence suggests that it may influence the 
collagen fibrillar  network in cartilaginous  tissue by regu- 
lating the lateral growth of the fibrils (Mendler et al., 1989; 
Petit et al., 1993). This putative function is supported by 
the recent identification of an al(XI) null mutation in cho/ 
cho (chondrodysplasia) mice, where the cartilage  lacking 
al(XI) collagen chains showed abnormally thick collagen 
fibrils (Li et al., 1995). Furthermore, the identification of 
e~2(XI) collagen  mutation as a cause  of certain forms of 
human  osteochondrodysplasia,  Stickler  syndrome,  and 
otospondylo-megaepiphyseat  dysplasia, indicates that type 
XI collagen is intimately involved in skeletal morphogene- 
sis (Vikkula et al., 1995). 
Expression of the three subunits of the type XI collagen 
molecule follows a distinct tissue-specific pattern (Lui et al., 
1995). In addition to its presence in cartilage,  the mRNA 
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non-cartilaginous tissues such as the bone, vitreous, heart, 
and cerebral neuro-epithelium (Yoshioka et al., 1995a). In 
some of these tissues, cd(XI) collagen has been suggested 
to form hybrid trimers with chains of type V collagen, indi- 
cating that type V and XI collagens may not necessarily be 
separate collagen entities (Mayne et al., 1993). The mRNA 
of the  type  II  collagen  gene,  which encodes  the a3(XI) 
chain as well as al(II) chain, is also detected in various tis- 
sues in addition to cartilage  (Cheah et al., 1991). On the 
other hand, expression of the c~2(XI)  collagen gene seems 
to be more restricted. Although low levels of alternatively 
spliced variants of a2(XI) transcripts are detected in vari- 
ous tissues  (Tsumaki  and Kimura,  1995), the major tran- 
script  is predominantly found in cartilage.  However,  the 
sequences responsible for this tissue-specific expression of 
the Collta2 gene have not been identified. 
In the present study, we attempted to define the cis-reg- 
ulatory regions  which  control et2(XI)  collagen  gene  ex- 
pression  during development.  For  this  purpose,  we  first 
characterized  the  5'  portion  of  the  mouse  c~2(XI)  gene 
(Collla2) 1. Then, to investigate the ability of the Collla2 
promoter to direct tissue-specific expression, we generated 
transgenic mice that harbored various combinations of cis- 
elements  linked  to  the  Escherichia  coli  13-galactosidase 
gene  (lacZ).  Our results  indicated  that a  sequence  from 
-742  to  +380 combined with the first intron of Collla2 
were sufficient to direct tissue-specific expression that was 
similar to that of the endogenous et2(XI) transcript. Inter- 
estingly, we also found that distinct sets of cis-elements  di- 
rected lacZ expression in the different components of the 
cartilaginous skeleton. 
Materials and Methods 
Characterization  of the Genomic Clone 
Fragments from the kNT8 mouse genomic clone (Tsumaki and Kimura, 
1995), which contained the 5'-flanking region of Collla2, were subcloned 
into pBluescript lI SK  ÷ (Stratagene Inc., La Jolla, CA) for nucleotide se- 
quence  analysis. Sequence  analysis of double-stranded  DNA  was  per- 
formed using Taq Dye Primer and Dye Deoxy Terminator cycle sequenc- 
ing  kits  (Applied  Biosystems Inc..  Foster  City,  CA)  together  with  an 
Applied Biosystems 373A DNA Sequencer. 
Determination of the Start Site 
To determine the sequence of the 5' portion of a2(XI) collagen mRNA, 
rapid amplification of cDNA ends (RACE) was done as described previ- 
ously (Tsumaki and Kimura, 1995). Briefly, Poly(A) + RNA was extracted 
from  the  thorax  of  1-d-old  mice  and  was  reverse-transcribed  using a 
Collla2-specific  primer  (5'  CGTTGTGGGGGCACTCTTCT 3', which 
was complementary to nt +373-+392) (see Fig. 1 for the location of the 
primers). After poly(dC) tailing, the eDNA was used as a PCR template 
by employing an adapter primer and another Coil la2-specific primer (5' 
TCGGTGGCCGCTACTGTGT 3', complementary to nt +335-+353) lo- 
cated just upstream of the reverse transcriptase primer. Then aliquots of 
the RACE products were purified by agarose gel electrophoresis, cloned 
into the plasmid vector, and sequenced as described above. 
1. Abbreviations used m  this paper:  Coll la2, the gene encoding murine 
a2(XI) collagen; nt, nucteotide(s); lacZ, the Escheriehia coli 13-galactosi- 
dase  gene;  p.c.,  postconception:  RACE,  rapid  amplification  of  cDNA 
ends; Rxrb,  the murine retinoid  X  receptor  13 gene; X-gal, 5-bromo-4- 
chloro-3-indolyl-13-D-galactopyranoside. 
S1 nuclease protection was done by the method described for double- 
stranded DNA probes (Sambrook et al., 1989).  Using the genomic frag- 
ment from hNT8 as a template, a 32p-labeled DNA probe (397 bp in size) 
was  generated  by  PCR  with  a  5'-end-32p-labeled  oligonucleotide  (5' 
ATGGTACACCCCTACTCCTG 3', complementary to nt +147-+ 166) 
and  an  un-labeled oligonucleotide  (5'  CAATTAGCACGTCACCCAT 
3', nt -231  to -213) as the primers. The end-labeled probe was purified 
using SupRec (Takara Inc., Shiga, Japan), and was hybridized for 16 h at 
57°C with either 25 p,g of total RNA from the rib cartilage of 4-wk-old 
mice or yeast tRNA. Then digestion was done with different concentra- 
tions of S1  nuclease (Takara Inc.). The reaction products were fraction- 
ated  on  denaturing 6%  polyacrylamide gel for  sizing relative  to  a  se- 
quence  reacted  with  the  same  end-labeled  primer  used  to  obtain  the 
double-stranded probe, after which bands on the dried gels were detected 
by autoradiography. 
For the primer extension experiments, an end-labeled oligonucleotide 
primer  (5'  ATCTFCTTCAGCCCCTTCAC  3',  complementary  to  nt 
+72-+91) was synthesized by attaching a fluorescent dye, 6-FAM amidite 
(Applied Biosystems Inc., Foster City, CA), to the 5' end. One picomole 
of the primer was combined with 7 l~g of poly(A) ÷ RNA from the thorax 
of 3-d-old mice, and extended with reverse transcriptase according to the 
previously described method (Sambrook et al., 1989). The extension prod- 
ucts were separated on denaturing 6% polyacrylamide gel for sizing rela- 
tive to a sequence reacted with the same fluorescent dye-labeled primer. 
Then signals from the bands were recorded and analyzed using Applied 
Biosystems 373A and GENESCAN software (Applied Biosystems Inc.). 
Construction  of Coll la2-1acZ Reporter Genes 
The expression vector used was pNASS13 (Clontech Inc., Palo Alto, CA), 
which contains a  polylinker site, an SV40 RNA splice site, the lacZ re- 
porter gene, and a SV40 polyadenylation signal. As described in Results, 
the putative 3' end of the retinoid X receptor 13 gene (Rxrb) was located 
742-bp upstream of the Collla2 transcription start site, suggesting that the 
promoter region of Coil la2 was localized within this 742-bp sequence. 
Two DNA segments of the Collla2 promoter were used: an 1.122-bp 
fragment between  -742 and  +380 was generated by PCR with  the ge- 
nomic subclone from hNT8 as the template using primers P-I  and Ex-l, 
while a 833-bp fragment between -453 and +380 was generated using the 
primers P-2 and Ex-1 (see Fig. 3 for the positions of the primers). To facil- 
itate  insertion  of  these  DNA  fragments  into  the  polylinker  site  of 
pNASS13, an ll-bp sequence containing the EcoRI site was added to the 
5' end of primers P-1  and P-2. Similarly, a sequence containing the Xhol 
site was added to the 5' end of primer Ex-1. After digestion with EcoR1 
and Xhol, the 1,122-bp and 833-bp DNA fragments were cloned into the 
EcoR/fXhoI polylinker region located upstream of the SV-40 splice siles 
of pNASSt3 to create two constructs (7421acZ and 4531acZ, respectively). 
A  2.3-kb DNA fragment covering most of the first intron of Collla2 
was also generated by PCR with the genomic subclone from kNT8 as the 
template using primers In-1 and In-2. These primers were tagged with 1 l-bp 
sequences containing the Sail and Pstl sites, respectively. After digestion 
with Sail and Pstl, the fragment was cloned into the Sall/Pstl polylinker 
region  located  downstream  of  the  SV-40  polyadenylation  signal  of 
742lacZ  and  4531acZ  to  create  two  more  constructs  (7421acZlnt  and 
4531acZInt, respectively). The  PCR  primers used were  as follows: P-l, 
GTCGCGAATTCAATAGCCAT]q-TCTGGACTGAGA;  P-2,  qTCC- 
CGAATTCTCTTGGTCACTTCAGCTT]~CACC;  Ex-1,  TACGTCTC- 
GAGACTCq~CI~GTCAGTGCTGCTTG;  In-I, TGGTAGTCGACTG- 
TCAGTCAGTTGAAGGTTGTAGCATC:  and In-2, CAGCTCTGCA- 
G CCAGATCTCAGTCTCCCTG  ACATI'CTC. 
Generation of Transgenic Mice 
The plasmids 7421acZ, 4531acZ, 7421acZlnt, and 453lacZInt were digested 
with EcoRI  and PstI to release the inserts from their vector sequences. 
Transgenic mice were produced by microinjecting each of the inserts into 
the pronuclei of fertilized eggs from F1 hybrid mice (C57BL/6 ×  C3H) as 
described previously (Hogan et al.. 1994).  Founder mice were identified 
by PCR assays of genomic DNA extracted from the placenta or tail.  The 
DNA was subjected to lacZ-specific PCR  with a  set of primers (sense, 
GCATCGAGCTGGGTAATAAGCGTTGGCAAT;  antisense. GACA- 
CCAGACCAACTGGTAATGGTAGCGAC)  to  amplify  an  822-bp 
product  (Hanley and Merlie,  1991).  Positive founder mice were  mated 
with wild-type mice to generate hemizygous embryos, and positive em- 
bryos were identified by PCR using placental DNA. 
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13-galactosidase  activity  was detected  in transgenic founder embryos or 
embryos obtained from transgenic mouse lines by staining with X-gal  (5- 
bromo-4-chloro-3-indolyl-13-o-galactopyranoside;  Sigma  Chem.  Co.,  St. 
Louis, MO) according to the previously described technique (Bonnerot 
and Nicolas,  1993). Briefly,  the embryos were fixed  in 4% paraformalde- 
hyde for 1540 min according to their size, and were stained with X-gal for 
2-7 h at 30°C. The reaction was stopped by washing in phosphate-buffered 
saline and postfixing in 4%  paraformaldehyde.  In some embryos more 
than 13.5 d postconception (p.c.),  the spinal columns and limbs were dis- 
sected and processed in the same manner. All solutions used were buff- 
ered at pH 7.4 to eliminate the endogenous 13-galactosidase activity.  For 
histological  examination, stained embryos and dissected tissues were em- 
bedded in Tissue-Tek  ®  O.C.T. compound (Miles Inc., Elkhart, IN) for cryo- 
stat sectioning, or were dehydrated, embedded in paraffin, and sectioned 
on a microtome. Then the sections were counterstained with eosin. 
Results 
Structural Analysis of the 5 '-Portion of Col  l la2 
Previously,  several  cDNA  clones  of mouse  a2(XI)  col- 
lagen have been isolated (Tsumaki and Kimura, 1995).  In 
the present  study, we used the RACE method to obtain a 
cDNA clone which further extended  507 bp upstream  of 
the ATG codon (Fig. 1). Comparison of the sequences of 
the  cDNA clones with  those  of genomic subclones  from 
XNT8 suggested that the untranslated sequence resided in 
a  single exon. The 5' end of this exon was mapped by S1 
nuclease  protection  using  an  end-labeled  397-bp  DNA 
fragment and  166-170 nt protected fragments were found 
(Fig. 2),  indicating  that the  end  of the  exon was located 
516-520 bp upstream  of the translational  start codon. To 
confirm the 5' boundary of exon 1, a primer extension ex- 
periment  was performed using  a  primer located 426-445 
bp upstream  of the translational  start  codon. The primer 
yielded a single major extension product of 91 bp (Fig. 2). 
From these results,  we determined  that the G  residue  lo- 
cated 516 bp upstream of the translational start codon was 
the major transcriptional start site. 
Sequence  analysis of the 5' flanking region of Collla2 
showed that the putative Y-end of the retinoid X  receptor 
13 cDNA sequence (Hamada et al.,  1989) was located 742 
bp  upstream  of  the  transcriptional  start  site  (Fig.  1). 
Therefore,  we  speculated  that  the  promoter  region  of 
Collla2  was  localized  within  this  742-bp  stretch,  which 
was identical to the recently reported mouse Co111a2 se- 
quence with the exception of 2 bp and showed marked ho- 
mology to that of the human gene (Vuoristo et al., 1995). 
Comparison of the sequence of the Collla2 promoter with 
consensus regulatory elements  showed that  there  was no 
apparent TATA box or CCAAT element. However, there 
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CCATCTTTCA  CTTGCACATA  AAGTTGCTTT  CCAGTTAAAA  TAGCCATTTT  CTGGACTGAG 
ATAACTATAT~-~TGGG  CACCAGGGCA  TCTACCTGTG  GGGATATCCG  GTGAGAAACC 
CTGACATGTT  CCCTGGATGC  TGCCACGGCC  TGAGGTTCCC 
AGGGTGGGGG  ACACAAGGCG  TGCTTTGTCG  GGAGGGGGAG 
CG~GGCTGCC  CAGGGAGGAG  GGAGAGCGGC  TGCTTTTCAA 
CCCTTCCAGC  GCCAGC[~'G-~GGCGTCT  TGGTCACTTC 
CACAGGCTCC  TGGCAGACCC  GGCACTGTGC  CCACGCTTAG 
TACCCTCCTA  GAACGGCCAC  GACCCTGAGT  GACCCTCTTT 
ATCGCCCCCC  CCCACCCCGT  ACCCCTTTTC  ATTCTGCTTC 
CTTTGGGGGC  AATTAGCACG  TCACCCATCT  CAGCTTTCTC 
CGCCCCCCAC  CTTTGGGTCG  CTATCTATAG  CTGGGTCTAT 
CTCTGTAATT  ACATGTGGCA  GGACGAGGGA  GGTAATTATG 
TGGGCCTACA  GAGCCGGTGC 
AGGGTGTGCC  AGGTTG~GGG 
AGGCGCCTTG  TTTGCCGGTG 
AGCTTTCACC  CTGGCTTCGC 
GGGTGCGCTG  CTCTCAGCGA 
TGCCAGACCT  TTCCATCAGC 
ACCTAGTCCA  GTATTTTTAT 
CGTTCCGCAG  GGCGACCCTA 
AAACACCI~-~GGACTG 
GAGAGCTGAT  TACGAGTGGG 
OOOO 
CGTGGAACGG  TCGCCCGTAG  GC~-~T  TCTGTCCCAC  TGTGCCCTGA  GTCCCTCCCC 
GGACTCTTCA  TAGGGGCTCT  GGGCCCCCAA  GGGCAGCTGC CGTGGTGTGA  AAGGACTATA 
GGATCATAAA  AGTGAAGGGG  CTGAAGAAGA  TATATTCTGT  TCCCACAAAT  GCCATCTGAG 
GGGGCACGCG  AGCTACCTAA  TCCCTCCAGG 
GTGAGGAAGG  TTTCCAACCC  TCACACTCTC 
CCCTTGGTGG  CTGT~-~-C~GCGTCAGGAG 
CTGGGGTCTC  TGAGCTGCCA  GGGTGGCCAG 
GCAGCACTGA  CA~GAAGAGT  GCCCCCACAA 
GAAAGCTGCT  GACATCCCGG  GGTCCTGGTT 
AGCACCAGGA  CTGCCTGGGA  TCTGGCATTC 
AGTAGGGGTG  TACCATTCCA  GGGCTAGCGA 
CTGCCCAGGT  GGAGATCGGG  GTGGGGTTTC 
GCGGGAGCTG  GACCTAGGGA  CGGGGGCGAG 
GGAC~CACAG  TAGCGGCCAC  CGAAGAGCAA 
CGGCACCTTG  CTGCATGGAG  CTGGGCCACT 
CCGAGGCTCA  GCTGGCTTCT  GTCTGCTGTC 
TGAGCCATGG  AGCGGTGCAG  CCGCTGCCAC 
Figure  1.  Nucleotide  se- 
quences of the mouse a2(XI) 
collagen promoter and 5'-un- 
translated  region.  The  tran- 
scription start site is shown as 
+1  and  the  5'  end  of  the 
primer  extension  product  is 
indicated by the asterisk.  The 
5'  ends  of the  S1  nuclease- 
protected  bands  are  indi- 
cated  by  black  dots.  Note 
that there is neither a proper 
TATA  box  nor  a  CCAAT 
box within the first 100-bp se- 
quence.  The  putative  SP1 
recognition  sequences  are 
marked with boxes. The po- 
tential  Pax-1  recognition 
sites  are  underlined.  The 
closed  triangle  denotes  the 
putative Y-end of the retin- 
old  X  receptor  13  gene  se- 
quence.  The  putative  trans- 
lation  start  eodon  is 
underscored  by  bold  line. 
The  horizontal  arrows show 
the  positions  of  the  nested 
primers used for RACE. The 
vertical  arrow  indicates  5' 
end  of the  RACE  product. 
The  horizontal  half-arrow 
marks the location of the oli- 
gonucleotide  primer  used 
for primer extension analysis. 
These  sequence  data  are 
available  from  GenBank/ 
EMBL/DDBJ  under  acces- 
sion number D84066. 
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Figure 3.  Diagrams  of  the  DNA  constructs  used  to  generate 
Collla2-lacZ  transgenic  mice.  The  gene  structure  around  the 
mouse Rxrb/Collla2 junction is shown at the top. Boxes indicate 
the coding regions and solid lines denote non-coding sequences. 
Horizontal arrows indicate the positions of the primers used for 
construction. The open arrow marks the location of the transla- 
tion initiation site of Collla2. The various transgenes are shown 
below the genomic map. A  bracket represents the SV-40 intron 
cassette, and arrowheads indicate ATG codon for lacZ. 
Figure 2.  Determination of the transcription start site of Collla2. 
(a) Primer extension mapping using mRNA from mouse thorax. 
The position of fluorescent-labeled primer used for the experi- 
ment is shown in Fig.  1 and begins at  +91. After separation on 
denaturing polyacrylamide gel,  signals  were recorded and ana- 
lyzed using Applied Biosysems 373A and GENESCAN software. 
The extension products are shown in lane 1, while  the adjacent 
lanes show a sequence ladder of the corresponding genomic se- 
quence  processed  using  the  same  primer.  (b)  The  results  of 
primer extension and S1 nuclease protection studies.  Along the 
DNA sequence of the antisense strand, the 5' end of the exten- 
sion  product is  indicated  by an  asterisk  and  the  S1  protected 
bands by black dots. (c) $1 nuclease mapping using a 397-bp end- 
labeled DNA probe (nt -231 to +166 in Fig. 1). The probe was 
annealed  with  RNA from mouse  costal cartilage  (lane  1)  and 
with yeast tRNA (lane 2). Sequencing reactions using the primer 
beginning at + 166 are shown in the adjacent lanes. 
were several potential SP1 binding sites (Fig. 1) typical of 
such TATA-Iess class promoters (Kageyama et al., 1989). 
Production of Transgenic Mice Bearing 
Coil la2-1acZ Constructs 
To identify the cis-regions  responsible  for the tissue-spe- 
cific expression of Co111a2, we prepared DNA constructs 
containing various  Collla2 fragments  linked  to the lacZ 
reporter  gene. In addition  to the promoter sequence, the 
first  intron  sequence  of  Collla2  was  used  to  generate 
transgene  constructs  (Fig.  3),  since previous studies  have 
shown  that  other  fibrillar  collagen  genes,  including  the 
al(I) gene (Hartung et al., 1986), et2(I) gene (Rossi and de 
Crombrugghe, 1987), and al(II) gene (Horton et al., 1987) 
possess elements with enhancer activity in the first intron. 
The constructs 7421acZ and 453lacZ contained the 742 and 
453 bp promoter sequences, respectively, while 7421acZInt 
and 4531acZInt  also harbored the first intron sequence in 
addition to the respective promoters. 
By microinjecting these  DNA constructs into fertilized 
eggs, independent  transgenic  mouse lines were generated 
(Table I). Five of the six transgenic lines bearing 742/acZInt 
exhibited  detectable  13-galactosidase  activity  on  X-gal 
staining. All four transgenic lines bearing 4531acZInt  also 
expressed  detectable  13-galactosidase  activity.  Although 
there Were variations in the level of transgene  expression 
between these lines, the overall pattern of 13-galactosidase 
expression was similar. For 742lacZ and 4531acZ, one line 
each was found to express [3-galactosidase activity. There- 
fore, additional  X-gal staining analysis was performed  in 
founder  embryos.  For 7421acZ, three  transgenic  founder 
embryos showed 13-galactosidase activity and all three had 
a pattern of expression  that was similar to each other and 
to  that  of the  established  transgenic  line.  In  the  case  of 
4531acZ, however,  four  out  of seven  transgenic  founder 
embryos showed 13-galactosidase activity, and the pattern 
of expression was variable. 
c~2(XI) Collagen-lacZ Transgene Expression during 
Murine Development 
To assess the pattern  of expression  of the transgenes,  we 
stained transgenic embryos with X-gal. The different lacZ 
expression patterns  directed  by DNA constructs contain- 
ing various cis-regions  are shown in Fig. 4. On 11.5 d p.c., 
7421acZInt, containing the entire promoter and first intron 
sequences, directed lacZ expression exclusively in the no- 
tochord  (Fig.  4  a).  Deletion  of the  289-bp  upstream  se- 
quence of the promoter region (453lacZInt) did not affect 
the  pattern  of lacZ expression  (Fig.  4  b).  On  the  other 
hand, deletion of the first intron sequence (742lacZ) led to 
Table L Production Frequency of Transgenic Mice 
Number of  Number of 
Transgene  embryos  transgenic 
construct  obtained  mice 
Number oftransgenic  Number of directly 
lines expressing  analyzed transgenic 
[?,-galactosidase*  founder embryos  ~ 
742lacZInt  35  9  5/6  ND 
453lacZInt  31  7  4/4  ND 
7421acZ  23  5  1/2  3/3 
4531acZ  43  8  1  / 1  4/7 
* lacZ-expressing  lines/transgenic lines established. 
~:lacZ-expressing  embryos/founder  embryos stained with X-gal. 
ND, not done. 
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there was also no lacZ expression in the notochord (not 
shown). 
By 13.5  d  p.c., chondrogenesis has commenced in  the 
limbs,  axial skeleton, and thorax. The scapula,  humerus, 
ulna, and radius of the forelimb are recognizable at this 
stage,  and  the  primordial  cartilage  of the  hindlimbs  is 
also present. Three Collla2-1acZ constructs (7421acZInt, 
4531acZInt, and 742lacZ) directed similar overall lacZ ex- 
pression pattern in these cartilaginous components of the 
skeleton (Figs. 4, d-f) despite some variations in the level 
of transgene  expression  between  lines.  In  mice  bearing 
7421acZ, however, staining  of the  limb  and rib cartilage 
tended  to  be  weaker,  and  the  future  petrous  temporal 
bone  was  more  marked  than  in  the  mice  bearing other 
constructs (Fig. 4f). 
Although 7421acZInt, 4531acZInt, and 7421acZ initially 
mediated  similar  13-galactosidase  expression  pattern  in 
limb cartilage, marked differences were noted by 15.5  d 
p.c.,  which  is  when  the  distal  components of the  limbs, 
such as the carpals, metacarpals, and phalanges, undergo 
chondrification.  As  shown  in  Fig.  4  g,  the  construct 
742lacZInt  containing the entire promoter and first intron 
sequences directed lacZ expression throughout the entire 
primordial cartilage of the forelimbs. On the other hand, 
deletion of the 289-bp upstream sequence of the promoter 
region (453lacZInt)  resulted in specific loss of expression 
in the primordial cartilage of the carpals (Fig. 4 h). The ex- 
pression in the primordial cartilage of the metacarpals and 
phalanges remained unaffected, and the mineralized dia- 
physeal regions seemed to show more [3-galactosidase ac- 
tivity.  Similarly,  deletion  of  the  first  intron  sequence 
(7421acZ) from 7421acZInt resulted in loss of expression in 
the carpals (Fig. 4 i) In the hindlimbs, each transgene di- 
rected similar, but slightly less distinct, patterns of lacZ ex- 
pression to those seen in the forelimbs (Figs. 4, j-l). 
Transgenic embryos bearing 453lacZ did not show lacZ 
expression in cartilage. In these embryos, the staining in- 
tensity was weak and variable among four founder mice 
and mice from one established lines (not shown). This re- 
sult was probably influenced by the site of transgene inte- 
gration (Allen et al., 1988), and suggested that the 453-bp 
promoter in the absence of the first intron lacked tissue- 
specific activity. 
Anatomical Analysis of Transgene Expression during 
Spinal Column Development 
To investigate transgene expression in the axial skeleton 
during  embryonic development, we  dissected  the  spinal 
columns out of transgenic mice at various stages of gesta- 
tion, stained them with X-gal, and viewed the specimens 
from the ventral side. As already demonstrated in Figs. 4, 
a-c, 742lacZInt  and 4531acZInt directed lacZ expression 
mainly in the notochord on 12.5 d p.c. (Figs. 5, a and b). 
On  the  other  hand,  deletion  of  the  intron  sequence 
(742lacZ)  eliminated  lacZ  expression  in  the  notochord 
(Fig. 5 c). 
On 13.5 d p.c., the notochord began to show segmental 
degeneration where sclerotome cells formed the cartilagi- 
nous precursors of the vertebral bodies. Cartilaginous ele- 
ments also appeared in the precursors of the ribs and the 
neural arches extending posteriorly along the lateral sur- 
face of the spinal cord. The longest construct (742lacZInt) 
directed lacZ expression in the notochord remnant and in 
the  primordial  cartilage  of the  vertebral  bodies,  neural 
arches, and ribs (Fig. 5 d). On the other hand, deletion of 
the  289-bp  upstream  sequence  of the  promoter  region 
(453lacZInt)  resulted in remarkable loss of lacZ expres- 
sion in the cartilage of the vertebral bodies, whereas ex- 
pression  in  the  notochord remnant  and  cartilage  of the 
neural arches and ribs remained unaffected (Fig. 5 e). Sim- 
ilarly, lack of the intron sequence (742lacZ) resulted in al- 
most complete loss of lacZ expression in the cartilage of 
the vertebral bodies, as well as in the notochord remnant 
(Fig. 5 f). 
On  15.5  d  p.c., both 742lacZInt  and 453lacZInt  main- 
tained  the  expression  of lacZ  in  the  nucleus  pulposus, 
which developed from the notochord remnant (Figs. 5, g 
and h). However, 7421acZ did not direct lacZ expression in 
the nucleus pulposus (Fig. 5 i). 
Histological Analysis of Transgene Expression 
Macroscopic observation revealed that the entire promoter 
and  the  first intron  sequences were  sufficient to confer 
lacZ expression in the primordial cartilage of the skeleton 
and in the notochord/nucleus pulposus. To further deter- 
mine the nature of the cells which showed [3-galactosidase 
activity in the primordial cartilage, we performed histolog- 
ical examination of transgenic embryos bearing 742lacZInt. 
By 12.5 d p.c., 7421acZInt started to direct [3-galactosidase 
expression in distinct portions of the limb buds in addition 
to the notochord (Fig. 6 a). Examination of transverse sec- 
tions  indicated  that  the  condensing  cells  showed  X-gal 
staining (Figs. 6, b and c), suggesting that 7421acZInt was 
activated in mesenchymal cells after they aggregated into 
condensations. 
As the condensations differentiated into primordial car- 
tilage, various types of chondrocytes became recognizable. 
Histological examination  of the  forelimb on  15.5  d  p.c. 
showed that 742lacZInt  directed lacZ expression in cells 
ranging from resting  to  hypertrophic chondrocytes with 
the most intense staining being noted in the proliferating 
chondrocytes (Fig. 6 d). The pattern of expression directed 
by 742lacZInt  was similar to that of endogenous u2(XI) 
collagen  as  determined  using  in  situ  hybridization (Sugi- 
moto, M., T. Kimura, N. Tsumaki, Y. Matsui, K. Nakata, Y. 
Kitamura, S. Nomura, T. Ochi, manuscript in preparation), 
except that expression of the transgene was slightly stron- 
ger in the hypertrophic zone. 
The differences in  the  patterns  of lacZ expression di- 
rected by each of transgene construct were confirmed by 
histological examination of the spinal columns. Parasagit- 
tal sections of the spines from 14.5 d p.c. embryos showed 
that 742lacZInt  directed lacZ expression in primordial car- 
tilage of the vertebral bodies as well as in the nucleus pul- 
posus and  the diminishing  notochord (Fig. 7 a).  On  the 
other hand, deletion of the 289-bp upstream sequence of 
the promoter region (4531acZInt)  resulted in the loss of 
detectable expression in the primordial cartilage of verte- 
bral bodies, whereas expression in the nucleus pulposus 
and diminishing notochord remained unaffected (Fig. 7 b). 
Deletion of the intron sequence (742lacZ) similarly elimi- 
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bral bodies, and also led to the loss of expression in the nu- 
cleus pulposus and diminishing notochord (Fig. 7 c). 
Discussion 
In this study, we defined the ability of the  Collla2 gene 
promoter to direct tissue-specific expression in transgenic 
mice. Firstly, we cloned and sequenced the 5' flanking re- 
gion  of  Collla2  and  determined  the  transcription  start 
site.  Our  findings,  as well as  those  recently reported  by 
others (Vuoristo et al., 1995), indicated that Collla2 was 
located close to the Rxrb gene in  a  head-to-tail arrange- 
ment. The distance between the putative 3' end of Rxrb 
and the  transcription  start site of Collla2  was ~742  bp, 
suggesting that the  Collla2  promoter was located within 
this segment. 
The  transgenic  mouse  experiment  indicated  that  the 
-742-bp promoter (7421acZ) contained information which 
conferred strong tissue specificity of expression. This seg- 
ment was active in most cartilaginous tissues during em- 
bryonic development, while the shorter segment, a -453-bp 
promoter (4531acZ), was much less active in these tissues. 
In addition, the shorter promoter by itself showed variabil- 
ity among founder embryos in the pattern of expression, 
probably reflecting the influence of the site of integration 
(Allen et al.,  1988).  It is therefore likely that part of the 
putative  cartilage-specific  element  is  located  between 
-742 and -453. Although the -742-bp promoter seemed 
to confer a high level expression on the reporter lacZ, the 
spatiotemporal profile of expression was not identical  to 
that  of endogenous  ct2(XI)  collagen.  Specifically,  trans- 
genic mice bearing the -742-bp promoter did not express 
the transgene in the notochord and the transgene was also 
distinctively inactive in the primordial cartilage of the ver- 
tebral bodies and of small bones including the carpals and 
tarsals. 
The first intron of several collagen genes seems to con- 
tain elements that are required to obtain a high level of ex- 
pression  and/or  tissue-specific  expression.  For  example, 
the first intron of the cd(II) collagen gene has been shown 
to  contain  an  enhancer  element  which  is  important  for 
strong tissue-specific expression in chondrocytes  (Zhou 
et al., 1995; Krebsbach et al., 1996). Our present data also 
support this concept. The transgene bearing the -742 pro- 
moter and first intron sequences (7421acZInt) initially di- 
rected 13-galactosidase expression in the notochord on 11.5 
d p.c. and then in all of the cartilaginous tissues (including 
the carpals, tarsals, and vertebral bodies)  after chondro- 
genic  differentiation  occurred  in  the  embryos. The  spa- 
tiotemporal  pattern  of expression  driven  by  7421acZInt 
largely mimicked that of the endogenous gene during em- 
bryonic development. Thus, the first intron seemed to con- 
tain elements that are necessary for mediating the expres- 
sion of this gene in the notochord and certain cartilaginous 
tissues. 
The first intron sequence was also capable of mediating 
a high level expression together with the -453 promoter, 
although the latter had only a low level of activity by itself. 
In the case of 4531acZInt,  there was initial  expression in 
the  notochord  and  then  in  the  notochord  remnants/nu- 
cleus pulposus and most of the cartilaginous skeleton, ex- 
cept for the carpals, tarsals, and vertebral bodies. Taken 
together, our findings suggest a  modular arrangement of 
the cis-acfing elements in the Collla2 promoter and first 
intron, which control the expression of this gene in differ- 
ent  parts  of  skeleton  during  embryonic  development. 
There  appeared  to  be  several different  cell-specific ele- 
ments. First, an element that promoted a high level gene 
expression  in  most  chondrocytes  was  located  between 
-742  and  -453  bp.  Second,  an element necessary for a 
high level of expression in the notochord and nucleus pul- 
posus  was  located  within  the  2.3-kb  first  intron.  Third, 
there was an element in the first intron that directed a high 
level of expression in  most chondrocytes in  cooperation 
with the -453-bp promoter. Fourth, an element of the first 
intron, in cooperation with an element between -742 and 
-453 bp, specifically directed a high level of expression of 
in the primordial cartilage of the carpals, tarsals, and ver- 
tebral bodies. 
The distinctive absence of lacZ expression in the carpals 
of the transgenic mice bearing 742lacZ or 4531acZInt sug- 
gests  that  a  close  regulatory  relationship  may exist  be- 
tween  the  Collla2  and  Hox  genes.  Hox  genes  encode 
transcription  factors  that  specify  regional  information 
along the embryonic axes (Krumlauf, 1994).  During limb 
development,  these  genes  are  activated  sequentially  to 
create a transcriptional cascade from the Hox-9 to Hox-13 
paralogues in the limbs. Davis et al.  have proposed that 
the order of activation and interaction of these paralogues 
specifies  the  pattern  of  prechondrogenic  condensation 
along  the  proximodistal  axis  (Davis  et  al.,  1995);  Hox 
group 9 genes may specify the scapula, Hox-lO genes spec- 
ify the humerus, Hox-ll genes specify the radius and ulna, 
Hox-12 genes specify the carpals, and Hox-13 genes spec- 
ify the  metacarpals and  phalanges.  Considering  the  spe- 
Figure 4.  Transgenic embryos and limbs at various stages  of development  illustrating expression of the 7421acZInt, 4531acZInt,  and 
7421acZ transgenes.  (a-c) Whole-mount embryos (11.5 d p.c.) stained  with X-gal. (a) A 7421acZInt transgenic  embryo with transgene 
expression  in the notochord (arrowheads).  (b) A  4531acZInt transgenic  embryo also expressing lacZ exclusively in the notochord (ar- 
rowheads). (c) A  742lacZ transgenic  embryo showing no expression  throughout the body. (d-f) Whole-mount embryos (13.5 d p.c.) 
stained with X-gal. An identical pattern of tacZ expression is seen in the primordial cartilage of the limb bones and ribs in each trans- 
genic embryo harboring 7421acZInt  (d), 4531acZInt  (e), and 742lacZ 0% (g-i) Forelimbs of 15.5 d p.c. transgenic  embryos. (g) The 
7421acZInt transgene directed lacZ expression in the primordial cartilage of the carpal bones (arrow) as well as in the cartilage of the hu- 
merus, ulna, radius, metacarpals, and phalanges.  On the other hand, 4531acZInt (h) and 742lacZ (i) failed to direct [3-galactosidase ex- 
pression  in the primordial cartilage  of the carpal bones, although  cartilage  of the other limb bones showed X-gal staining. (j-l) Hind- 
limbs of 15.5 days p.c. transgenic  embryos. (j) The 7421acZInt  transgene directed  lacZ expression  in the primordial cartilage  of the 
tarsals (arrow) as well as in the cartilage of the femur, tibia, fibula, metatarsals,  and phalanges.  On the other hand, 4531acZInt (k) and 
742lacZ (l) caused minimal 13-galactosidase expression in the cartilage of the tarsal bones, while that of other limb bones showed strong 
X-gal staining. Bars, 1 ram. 
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4531acZInt,  and  7421acZ transgenes  in  the  spine  at  different 
stages of development. The spinal  columns with ribs were dis- 
sected out, stained with X-gal, and viewed from the ventral side. 
(a-c) Spinal  columns of 12.5 d p.c. transgenic embryos, lacZ ex- 
pression  is  mainly  directed  in  the  notochord  (arrowhead)  by 
7421acZInt (a) and 4531acZInt (b), but little  X-gal staining is visi- 
ble in the 7421acZ transgenic mouse (c). (d-f) 13-galactosidase ex- 
pression in the spinal  columns of 13.5 d p.c. transgenic embryos. 
(d)  X-gal  staining  is  visible  in  the  notochord remnant  (arrow- 
head)  and primordial cartilage of the vertebral bodies  (arrow), 
neural arches, and ribs in transgenic mice bearing 7421acZInt. (e) 
On the  other  hand,  4531acZInt  did  not direct  [3-galactosidase 
activity in the cartilage of the vertebral  bodies,  although the 
notochord  remnants  (arrowhead)  and  cartilage  of  the  neural 
arches and ribs showed X-gal staining.  (f) Furthermore, 7421aeZ 
conferred no expression on the notochord remnants  and weak 
expression on the vertebral body precursors, whereas the primor- 
dial  cartilage  of  the  neural  arches  and  ribs  showed  [3-galac- 
cific loss of lacZ expression in the carpals of our transgenic 
mice bearing 742IacZ or 4531acZInt,  it is  tempting  to as- 
sume  that  certain  element(s)  may  reside  between  -742 
and  -453 bp and within the first intron of Collla2  which 
directly  or indirectly  interact  with  Hox proteins.  Activa- 
tion of Hox  genes such  as  Hox-12  in the  limb  buds may 
cause cells to differentiate and to express genes encoding 
cartilage matrix molecules, including ~2(XI) collagen, thus 
forming the primordial cartilage of the carpals. 
The distinctive absence of lacZ expression in the verte- 
bral bodies of transgenic mice bearing 7421acZ and 4531acZInt, 
on the other hand, reminds us of the Pax-1 mouse mutants, 
Undulated short-tail, in which whole Pax-1 locus is deleted. 
Vertebral bodies are virtually absent in these Pax-l-nega- 
tive mice, while  the neural  arches  are  fairly normal, sug- 
gesting that Pax-1 is essential for ventral sclerotome differ- 
entiation  into  primordial  cartilage  of  vertebral  bodies 
(Wallin et al., 1994). Since Pax-1 encodes a transcriptional 
factor, it is possible that certain elements may exist in the 
upstream sequence of promoter region and within the first 
intron of Collla2 which directly or indirectly interact with 
Pax-1  gene  products.  Indeed,  we  found  two  sites  of 
GTTCC core  motifs  recognized  by Pax-1  (Chalepakis  et 
al., 1991) within the 289 bp upstream sequence of the pro- 
moter (-653 to  -649 and  -626 to  -622) and seven sites 
within the first intron (data not shown) of Collla2. 
Gross  examination  of  the  promoter  sequence  of  the 
Collla2  showed  only  low  overall  homology  with  other 
genes which are predominantly expressed  in cartilage  in- 
cluding the mouse al(II) collagen gene (Metsaranta  et al., 
1991), the human al(XI)  collagen gene  (Yoshioka  et  al., 
1995b), the rat aggrecan gene (Doege et al., 1994), and the 
rat link protein gene (Rhodes et al., 1991). However, close 
examination  searching for elements  with  a  length  of sev- 
eral  nucleotides  revealed  that  the  sequence  at  -142  to 
-135 of Collta2  was quite similar to the complementary 
sequence of the AT-rich element in the first intron of the 
type II collagen gene.  This  element  is  essential  for carti- 
lage-specific expression of the gene, and is a nuclear-factor 
binding site (Krebsbach et al., 1996). In addition, the DNA 
element located at  -74  to  -68  of Collla2  resembles  the 
nuclear  protein-bound  sequence  (-387  to  -381)  in  the 
promoter  of the  ~I(XI)  collagen  gene  (Yoshioka  et  al., 
1995b).  However,  the  dissimilarity  of other  regions  may 
account for the distinctive pattern of c~2(XI) chain expres- 
sion among the subunits of the type XI collagen molecule 
and  other matrix  proteins  specifically expressed  in  carti- 
lage. 
This  study  provides  a  starting  point  for understanding 
the mechanism by which expression of the c~2(XI) collagen 
gene is regulated. Experiments are in progress to elucidate 
further  details  of arrangement  of the  cis-elements  of the 
tosidase expression.  (g-i) Spinal columns of 15.5 d p.c. transgenic 
embryos. (g) There  is obvious X-gal  staining in the primordial 
cartilage of vertebral bodies (arrow) and in the nucleus pulposus 
(arrowhead)  of the 7421acZlnt transgenic  embryo.  (h)  Isolated 
expression  of lacZ is directed  in  the  nucleus pulposus  (arrow- 
head)  by 4531acZlnt. (i) The spinal  column of a 7421acZ trans- 
genic mouse showing no  13-galactosidase expression  in  the  pri- 
mordial  cartilage  of the  vertebral  bodies  and  in  the  nucleus 
pulposus. Bars, 200 ~tm. 
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p.c. transgenic mice bearing various Collla2-lacZ constructs. (a) 
The transgenic mice bearing 7421acZInt expressed lacZ in the pri- 
mordial  cartilage  of the vertebral  bodies  (asterisk)  as well  as in 
the diminishing notochord (arrowhead) and the nucleus pulposus 
(arrow).  (b)  On  the  other  hand,  mice  bearing 4531acZInt  only 
showed X-gal staining in the diminishing notochord  (arrowhead) 
and nucleus pulposus (arrow), but not in the cartilage of the ver- 
tebral  bodies  (asterisk).  (c)  Mice  bearing 7421acZ expressed the 
reporter gene in neither the cartilage of the vertebral bodies (as- 
terisk)  nor  the  diminishing notochord  (arrowhead)  and  nucleus 
pulposus (arrow). Bars, 100 p,m. 
Figure 6.  Transgenic  mice  bearing  7421acZInt.  (a)  The  whole- 
mount embryo shows [?,-galactosidase expression in distinct por- 
tions of the limb buds in addition to the notochord (arrowheads). 
(b)  A  transverse section shows that 7421acZInt directed  !3-galac- 
tosidase expression in the notochord (arrowhead) and in the clus- 
ter of cells in the center of the forelimbs. The section was stained 
with  X-gal  and  counterstained  with  eosin.  (c)  A  higher  power 
view reveals that the X-gal-stained cells in the limbs are mesen- 
chymal  cells  aggregating  into  condensations.  (d)  Section  of  a 
forelimb  from  a  transgenic mouse  bearing  the  7421acZlnt  con- 
struct.  (e)  Section  of  a  forelimb  from  a  control  mouse  stained 
with safranin-O. The primordial cartilage of the radius, ulna, and 
carpals shows red staining. (a-c),  12.5 d  p.c. (d, and e),  15.5 d  p.c. 
Bars: (a) 1 mm; (b) 500 p,m; (c) 50 I~m; (d and e) 200 ~m. 
C0llla2  gene  using transgenic  mice  bearing  various  DNA 
constructs.  The  information  may  provide  additional  in- 
sights into  the  mechanisms  controlling  the  morphogenesis 
of various  skeletal  components. 
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